av/pacira-pharmaceuticals--big.svg

COM:PACIRA

Pacira Pharmaceuticals, Inc.

  • Stock

Last Close

17.03

21/11 21:00

Market Cap

946.75M

Beta: -

Volume Today

385.19K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
13.82M
-
22.41M
62.19%
45.45M
102.83%
46.46M
2.22%
36.34M
21.78%
44.99M
23.79%
53.43M
18.77%
61.47M
15.05%
81.60M
32.74%
97.31M
19.25%
average payables
2.82M
-
4.91M
74.30%
7.75M
57.70%
8.13M
4.86%
11.08M
36.42%
14.51M
30.93%
13.58M
6.40%
11.62M
14.49%
10.49M
9.71%
12.88M
22.83%
average receivables
9.47M
-
18.48M
95.10%
24.11M
30.48%
27.90M
15.70%
30.80M
10.40%
34.83M
13.09%
42.77M
22.79%
50.29M
17.59%
74.68M
48.51%
97.36M
30.36%
book value per share
1.24
-
4.85
290.02%
5.98
23.27%
5.88
1.61%
7.02
19.39%
7.85
11.83%
8.55
8.89%
14.52
69.85%
16.50
13.63%
17.03
3.17%
capex per share
-0.39
-
-0.62
60.83%
-1.13
82.14%
-0.66
41.25%
-0.48
27.06%
-0.35
26.70%
-0.24
31.02%
-0.89
262.00%
-1.04
16.97%
-0.66
36.24%
capex to depreciation
-2.23
-
-2.18
2.02%
-3.60
64.88%
-1.91
46.82%
-1.39
27.18%
-1.10
20.84%
-0.52
52.93%
-1.90
265.89%
-1.61
15.39%
-0.33
79.54%
capex to operating cash flow
0.30
-
-0.86
390.30%
-1.42
65.61%
-0.74
48.11%
-1.08
46.66%
-0.30
72.58%
-0.14
51.49%
-0.49
240.64%
-0.36
25.65%
-0.21
43.25%
capex to revenue
-0.15
-
-0.11
25.95%
-0.17
49.68%
-0.09
46.06%
-0.07
24.82%
-0.04
35.98%
-0.02
43.93%
-0.09
272.27%
-0.08
5.71%
-0.05
46.75%
cash per share
2.17
-
7.86
261.28%
7.14
9.10%
4.64
35.09%
7.82
68.74%
9.37
19.83%
7.03
24.97%
12.23
73.83%
14.83
21.31%
6.34
57.24%
days of inventory on hand
103.67
-
137.93
33.04%
313.21
127.09%
103.69
66.90%
171.93
65.81%
204.13
18.73%
199.40
2.32%
201.12
0.87%
256.47
27.52%
175.94
31.40%
days payables outstanding
20.45
-
31.85
55.75%
44.40
39.40%
24.90
43.92%
60.86
144.41%
60.39
0.77%
43.78
27.50%
32.45
25.88%
27.44
15.45%
27.87
1.60%
days sales outstanding
62.25
-
41.30
33.65%
37.90
8.23%
39.54
4.32%
40.31
1.96%
41.12
2.01%
41.21
0.20%
46.01
11.66%
64.92
41.10%
53.86
17.04%
debt to assets
1.17
-
0.63
45.74%
0.54
14.02%
0.28
48.92%
0.44
58.41%
0.42
4.09%
0.42
0.34%
0.42
0.26%
0.54
28.11%
0.45
16.52%
debt to equity
4.80
-
1.20
74.89%
0.97
19.48%
0.50
48.81%
0.99
99.23%
0.91
8.45%
0.99
9.47%
0.87
11.93%
1.55
76.99%
0.99
36.27%
dividend yield
0.00
-
0.00
72.38%
0.00
58.39%
earnings yield
-0.03
-
-0.00
86.92%
0.00
115.09%
-0.03
4,870.13%
-0.02
25.68%
-0.00
98.86%
-0.01
2,088.93%
0.06
1,072.89%
0.02
72.34%
0.01
42.58%
0.02
164.29%
enterprise value
1.99B
-
3.07B
54.18%
2.75B
10.46%
1.28B
53.67%
2.04B
59.90%
1.92B
5.94%
2.15B
12.29%
2.99B
39.01%
3.21B
7.08%
2.42B
24.63%
enterprise value over ebitda
-42.13
-
-622.13
1,376.63%
276.17
144.39%
-41.44
115.00%
-128.89
211.05%
83.09
164.47%
49.17
40.83%
44.79
8.91%
22.17
50.49%
19.90
10.26%
ev to operating cash flow
-46.14
-
120.72
361.62%
94.94
21.35%
38.13
59.84%
114.68
200.76%
39.26
65.77%
30.55
22.18%
38.87
27.26%
25.51
34.39%
16.64
34.77%
ev to sales
23.31
-
15.55
33.27%
11.06
28.92%
4.62
58.26%
7.12
54.17%
5.69
20.06%
5.12
10.04%
7.12
39.08%
5.92
16.79%
3.62
38.79%
free cash flow per share
-1.69
-
0.10
106.01%
-0.34
431.21%
0.23
169.91%
-0.04
115.84%
0.84
2,357.13%
1.45
73.14%
0.92
36.77%
1.80
96.22%
2.53
40.28%
2.76
8.87%
free cash flow yield
-0.03
-
0.00
103.90%
-0.00
482.40%
0.01
266.20%
-0.00
111.21%
0.02
2,495.11%
0.03
64.43%
0.02
52.13%
0.03
95.15%
0.07
118.61%
0.08
24.59%
graham net net
-1.14
-
4.36
483.47%
3.83
12.10%
1.03
73.21%
0.17
83.08%
1.66
859.35%
-2.88
272.72%
-1.43
50.24%
-12.81
795.35%
-10.89
14.99%
graham number
7.34
-
6.51
11.29%
2.61
59.86%
11.61
344.32%
13.00
11.98%
1.43
89.03%
7.14
400.99%
33.38
367.21%
18.77
43.78%
11.57
38.34%
income quality
0.68
-
-1.86
374.60%
15.62
941.35%
-0.88
105.64%
-0.42
52.65%
-103.76
24,759.32%
-6.40
93.83%
0.53
108.27%
2.99
465.73%
9.13
204.93%
intangibles to total assets
0.07
-
0.07
9.58%
0.08
7.23%
0.12
50.24%
0.09
26.42%
0.09
2.45%
0.25
172.66%
0.15
37.31%
0.37
140.91%
0.42
12.96%
0
100%
interest coverage
-7.35
-
-0.62
91.51%
1.22
296.16%
-4.54
470.55%
-1.38
69.53%
0.73
152.48%
1.61
122.44%
1.81
11.94%
4.13
128.63%
1.50
63.63%
-4.32
387.56%
interest debt per share
6.18
-
6.08
1.74%
6.01
1.10%
3.11
48.25%
7.40
137.94%
7.65
3.36%
9.05
18.29%
13.28
46.83%
26.22
97.40%
17.65
32.69%
inventory turnover
3.52
-
2.65
24.84%
1.17
55.96%
3.52
202.07%
2.12
39.69%
1.79
15.78%
1.83
2.37%
1.81
0.86%
1.42
21.58%
2.07
45.77%
invested capital
4.80
-
1.20
74.89%
0.97
19.48%
0.50
48.81%
0.99
99.23%
0.91
8.45%
0.99
9.47%
0.87
11.93%
1.55
76.99%
0.99
36.27%
market cap
1.91B
-
3.13B
64.06%
2.81B
10.34%
1.20B
57.14%
1.82B
51.09%
1.76B
3.15%
1.88B
6.85%
2.55B
35.78%
2.66B
4.30%
1.76B
34.01%
1.75B
0.22%
net current asset value
-21.82M
-
59.33M
371.91%
81.35M
37.12%
70.60M
13.22%
42.22M
40.19%
109.84M
160.15%
-67.56M
161.51%
-3.20M
95.26%
-478.90M
14,856.18%
-407.86M
14.83%
net debt to ebitda
-1.83
-
11.14
710.07%
-5.32
147.75%
-2.36
55.56%
-14.05
494.26%
6.86
148.82%
6.25
8.95%
6.60
5.62%
3.76
43.07%
5.43
44.48%
net income per share
-1.93
-
-0.39
79.83%
0.05
113.07%
-1.02
2,106.45%
-1.07
5.04%
-0.01
98.92%
-0.27
2,204.94%
3.41
1,385.17%
0.95
72.19%
0.35
63.15%
0.81
130.95%
operating cash flow per share
-1.30
-
0.72
155.40%
0.79
9.98%
0.90
13.21%
0.45
50.27%
1.19
167.36%
1.70
42.21%
1.81
6.27%
2.84
57.33%
3.19
12.36%
2.76
13.67%
payables turnover
17.85
-
11.46
35.79%
8.22
28.26%
14.66
78.33%
6.00
59.08%
6.04
0.78%
8.34
37.94%
11.25
34.91%
13.30
18.27%
13.09
1.57%
receivables turnover
5.86
-
8.84
50.72%
9.63
8.97%
9.23
4.14%
9.05
1.93%
8.88
1.97%
8.86
0.20%
7.93
10.44%
5.62
29.13%
6.78
20.53%
research and ddevelopement to revenue
0.25
-
0.09
62.40%
0.12
21.48%
0.17
43.58%
0.20
20.93%
0.17
17.39%
0.17
3.74%
0.14
17.57%
0.10
27.36%
0.13
23.98%
0.11
11.16%
return on tangible assets
-0.40
-
-0.05
88.74%
0.01
111.39%
-0.11
2,227.31%
-0.07
32.47%
-0.00
98.99%
-0.02
2,239.53%
0.13
868.19%
0.03
76.18%
0.02
49.36%
revenue per share
2.58
-
5.60
117.20%
6.81
21.69%
7.42
8.92%
7.20
2.98%
8.24
14.49%
10.14
23.02%
9.86
2.76%
12.23
24.06%
14.65
19.73%
12.99
11.35%
roe
-1.55
-
-0.08
94.83%
0.01
110.60%
-0.17
2,139.21%
-0.15
12.02%
-0.00
99.04%
-0.03
2,016.67%
0.23
856.65%
0.06
75.53%
0.02
64.28%
roic
-0.22
-
-0.01
93.74%
0.02
238.78%
-0.10
609.33%
-0.05
54.08%
0.03
164.03%
0.05
80.10%
0.27
422.11%
0.05
81.43%
0.04
11.50%
sales general and administrative to revenue
0.24
-
0.21
13.99%
0.25
16.85%
0.23
6.84%
0.23
1.43%
0.21
10.60%
0.17
18.80%
0.18
5.27%
0.16
8.28%
0.16
0.70%
shareholders equity per share
1.24
-
4.85
290.02%
5.98
23.27%
5.88
1.61%
7.02
19.39%
7.85
11.83%
8.55
8.89%
14.52
69.85%
16.50
13.63%
17.03
3.17%
stock based compensation to revenue
0.13
-
0.13
6.69%
0.13
6.72%
0.11
15.63%
0.11
2.49%
0.09
14.68%
0.08
15.03%
0.09
18.69%
0.08
17.76%
0.07
7.55%
0.07
1.61%
tangible asset value
29.76M
-
146.98M
393.82%
187.43M
27.52%
172.24M
8.11%
224.29M
30.22%
259.19M
15.56%
151.01M
41.74%
423.62M
180.52%
-38.73M
109.14%
71.22M
283.87%
tangible book value per share
0.90
-
4.16
364.21%
5.13
23.19%
4.63
9.82%
5.63
21.81%
6.34
12.44%
3.64
42.58%
9.93
172.91%
-0.88
108.82%
1.56
278.78%
working capital
-15.19M
-
74.25M
588.72%
100.91M
35.91%
198.25M
96.47%
334.89M
68.92%
417.31M
24.61%
300.88M
27.90%
398.30M
32.37%
344.93M
13.40%
350.56M
1.63%

All numbers in (except ratios and percentages)